Scientific Advisor for Clinical & Regulation of Drug Development
Kanabo Research

Pnina (Paula) Strauss-Levy has more than 20 years' experience in the pharma industry, serving as Vice President of clinical, IP and regulatory affairs in global, dually listed (NASDAQ & TASE) pharmaceutical firms. Ms. Strauss-Levy holds specific expertise in Orphan Drug space, Diabetes T1/2, Respiratory, Oncology, Vaccination and Medical-Cannabis drug development as well as IPO processes and Intellectual property.

Through her newly-established firm, “Strauss-Levy & Co Ltd,” she provides clinical management, supervision and consulting services to the pharma industry (phases, I-IV & PMS) including strategic clinical and regulatory planning (FDA/ EMA/ EU-CA/IMH oriented) and clinical project execution.

Ms. Strauss-Levy is also a formal clinical consultant and local focal point of PCI Pharma Services, a US, ful- service CMO provider and a lecturer at the MBA Bio-Medical program at the College of Management in Rishon Lezion.

Close Menu